Entity family

Browse diseases

Named diseases, disorders, syndromes, injuries, and health conditions. Examples include epilepsy, diabetes, stroke.

23,712articles mentioning diseases

125,551disease mentions

18,081distinct diseases extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted diseases

Showing 1,921–1,980 of 18,081, ordered by supporting articles. Choose a disease to see its evidence.

Leber Hereditary Optic Neuropathy4 Left Ventricular Systolic Dysfunction4 Li-Fraumeni Syndrome4 Liver dysfunction4 Lower back pain4 MC38 tumors4 Malignant pleural effusion (MPE)4 Mantle Cell Lymphoma4 Methicillin-resistant Staphylococcus aureus4 Motor neuron disease (MND)4 Neuromuscular diseases4 Normal pressure hydrocephalus (NPH)4 Obstructive sleep apnoea (OSA)4 Pelvic organ prolapse4 Pneumatosis Intestinalis4 Polyarteritis nodosa4 Polypoidal choroidal vasculopathy4 Portal vein thrombosis4 Posterior Circulation Aneurysms4 Postoperative nausea and vomiting (PONV)4 Postoperative pulmonary complications (PPCs)4 Premature Mortality4 Primary hyperparathyroidism4 Progressive multifocal leukoencephalopathy4 Pulmonary Veno-Occlusive Disease4 Pulmonary diseases4 Renal cell carcinoma (RCC)4 Retinal diseases4 Reversible cerebral vasoconstriction syndrome4 Streptococcus pneumoniae4 Torsades de Pointes4 Toxic epidermal necrolysis4 Traumatic injuries4 Treponema pallidum4 Tuberous sclerosis4 Type 2 diabetes (T2D)4 Type II diabetes4 Upper respiratory tract infections4 Vascular dementia4 acute rheumatic fever4 advanced liver fibrosis4 anterior circulation large vessel occlusion4 anti-phospholipid syndrome4 antineutrophil cytoplasmic antibody-associated vasculitis4 asthenia4 atherosclerotic cardiovascular disease (ASCVD)4 autism spectrum disorders4 autoimmune pancreatitis4 benign prostatic hyperplasia4 bicuspid aortic valve4 bullous pemphigoid4 cardiac surgery4 cardiopulmonary disease4 cardiovascular collapse4 cardiovascular mortality4 chronic intestinal failure4 chronic non-communicable diseases4 chronic respiratory conditions4 congenital diaphragmatic hernia4 connective tissue disorders4

View all 18,081 diseases on one page

Articles mentioning diseases

23,712 articles · page 273 of 1976

415 Treatment patterns of systemic therapies in extensive-stage small-cell lung cancer (ES-SCLC): a real-world observational study

jitc · abstract · 2025-11-04 · 9 matching annotations

96.7%

ES-SCLC small cell lung cancer tarlatamab atezolizumab durvalumab Merck Sharp & Dohme LLC carboplatin

…ons This study showed that while more than 70% of patients with ES-SCLC received ICI-containing regimens as first-line treatment, progn…

431 Immune checkpoint inhibitor for advanced cutaneous malignancies in organ transplant recipients: a case series from a single center experience

jitc · abstract · 2025-11-04 · 9 matching annotations

97.8%

Merkel cell carcinoma cutaneous malignancy melanoma squamous cell carcinoma cutaneous malignancies sirolimus Inova Schar Cancer Institute everolimus prednisone mycophenolate+4 more

…gnancies including melanoma, squamous cell carcinoma (SCC), and Merkel cell carcinoma (MCC). However, the concurrent use of ICIs and immunosuppressan…

435 ES038, a novel NKCE molecule targeting LILRB4 in AML via dual engagement of NKG2A and NKG2C

jitc · abstract · 2025-11-04 · 9 matching annotations

93.5%

AML Acute myeloid leukemia ES038 LILRB4

…es NK cell activation and improves their therapeutic potential. AML, particularly in relapsed or refractory cases, remains a signif…

463 Dissecting myeloid-driven mechanisms of immunotherapy resistance in prostate cancer bone metastases

jitc · abstract · 2025-11-04 · 9 matching annotations

94.4%

metastatic castration-resistant prostate cancer mCRPC pancreatic ductal carcinoma prostate cancer ipilimumab enzalutamide J Clin Oncol Atezolizumab

…al. Atezolizumab with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate cancer: a randomized phase 3 trial. Nat Med. 2022;28:144–53.Koo KC, Pa…

546 Sarilumab as a potential mitigator of ubamatamab (MUC16×CD3)-induced cytokine release syndrome (CRS) in patients with advanced ovarian cancer (OC) or endometrial cancer (EC)

jitc · abstract · 2025-11-04 · 9 matching annotations

96.0%

CRS OC recurrent advanced OC sarilumab ubamatamab

…4.Conclusions A single sarilumab dose before ubamatamab reduced CRS incidence and severity. Pharmacokinetic and pharmacodynamic fin…

640 CHS-114, an anti-CCR8 cytolytic monoclonal antibody demonstrates selective intratumoral Treg depletion and favorable immune remodeling in participants with advanced solid tumors

jitc · abstract · 2025-11-04 · 9 matching annotations

93.5%

head and neck squamous cell carcinoma advanced solid tumors HNSCC CHS-114

…ansion study is evaluating CHS-114 in advanced solid tumors and head and neck squamous cell carcinoma (HNSCC). CHS-114 has demonstrated an acceptable safety profile …

651 Imneskibart, a human monoclonal antibody (mAb) that binds IL-2 and prevents CD25 binding, + low-dose subcutaneous IL-2: phase 2 update on CPI-refractory melanoma and non-small cell lung cancer (NSCLC)

jitc · abstract · 2025-11-04 · 9 matching annotations

99.3%

Melanoma NSCLC Imneskibart Avelumab

…or regressions and a low incidence of Grade 3/4 adverse events. Melanoma patients with primary resistance to prior doublet immune checkp…

675 Radiopharmaceutical therapy enhances CAR T-cell activity against neuroblastoma by tumor sensitization and tumor microenvironment remodeling

jitc · abstract · 2025-11-04 · 9 matching annotations

94.4%

neuroblastoma solid tumors hematological malignancies SK-N-AS NB [67Cu]Cu-LLP2A [ 67Cu]Cu-LLP2A 67Cu]Cu-LLP2A NIH institutional IACUC RPT

…ell therapy remains less effective against solid tumors such as neuroblastoma (NB) than hematological malignancies. Key obstacles for CAR T c…

679 Combined radiation and adoptive CTL therapy in advanced extramammary paget disease with pulmonary and nodal metastases: a case report and rationale for case series expansion

jitc · abstract · 2025-11-04 · 9 matching annotations

92.6%

melanoma-specific Extramammary Paget’s disease (EMPD)EMPD melanoma solid tumors EBV-related cancers IL-2 Radiother Oncol Adoptive CTL therapy Proc Natl Acad Sci USA+1 more

…:62-68.Chapuis AG, Ragnarsson GB, Nguyen HN, et al. Transferred melanoma-specific CD8+ T cells persist, mediate tumor regression, and acquire cen…

708 Overcoming resistance to chemo-immunotherapy in non-small cell lung cancer by targeting adenosine metabolism and enhancing CD8+ T cell activation

jitc · abstract · 2025-11-04 · 9 matching annotations

93.5%

NSCLC non-small cell lung cancer A375 melanoma NSCLC-bearing cisplatin carboplatin cisplatin-induced cisplatin-treated PEG-ADA

… NSCLC cells. For T cell suppression assays, M-MDSCs from human NSCLC were cultured with autologous T cells stimulated with anti-CD3 …

725 Fertility concerns and outcomes among adolescent and young adult males with melanoma receiving immunotherapy

jitc · abstract · 2025-11-04 · 9 matching annotations

97.9%

melanoma microsatellite instability-high (MSI-H) tumors University of Michigan Immune checkpoint inhibitors ICIs first-line immunotherapy

…reatment, toxicity, and fertility characteristics of young male melanoma patients treated with immune checkpoint inhibitors (n=38)…

776 Melanoma tumor cells and immunotherapy cooperatively reprogram bone marrow niches to induce early hematopoietic dysfunction and therapy-related myeloid neoplasms

jitc · abstract · 2025-11-04 · 9 matching annotations

99.6%

Melanoma myelodysplastic syndromes therapy-related myeloid neoplasms immune checkpoint inhibitors immune checkpoint inhibitor therapy Embase PubMed Scopus

…rrow niche alterations and hematopoietic clonal dynamicsResults Melanoma tumor cells infiltrate the bone marrow early, with disseminated…